| Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992) |
|---|
| 04/26/2006 | EP1649003A2 Methods of producing differentiated hematopoietic cells for treatment of cytopenia |
| 04/26/2006 | EP1649002A2 Rna processing protein complexes and uses thereof |
| 04/26/2006 | EP1649000A2 Seeding pancreatic cells on porous matrices |
| 04/26/2006 | EP1648999A2 Systems and methods for separating and concentrating regenerative cells from tissue |
| 04/26/2006 | EP1648998A2 Specific binding agents to hepatocyte growth factor |
| 04/26/2006 | EP1648997A2 Methods of treatment and disgnosis using modulators of virus-induced cellular gene sequences |
| 04/26/2006 | EP1648995A2 Compositions for purifying and crystallizing molecules of interest |
| 04/26/2006 | EP1648918A2 Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof |
| 04/26/2006 | EP1648512A2 Anti-cd19 antibodies |
| 04/26/2006 | EP1648488A2 Human mast cell-expressed membrane protein |
| 04/26/2006 | EP1648477A2 Injection of bone marrow-derived cells and medium for angiogenesis |
| 04/26/2006 | EP1648429A2 Hexameric porphobilinogen synthase as a target for the development of antibiotics and herbicides |
| 04/26/2006 | EP1648397A2 Ex vivo progenitor and stem cell expansion for use in the treatment of disease of endodermally-derived organs |
| 04/26/2006 | EP1648233A2 Mutants of vaccinia virus as oncolytic agents |
| 04/26/2006 | CN1763194A 'Osteoclast-inhibitory factor' (ocif),its nucleotide sequence and methods for producing same |
| 04/26/2006 | CN1763181A Vaccine against mumps containing a JERYL-LYNN virus strain |
| 04/25/2006 | US7033592 Useful in vaccines, and monoclonal antibodies against said immunogenic surface proteins; hybridoma cell line that produes said antibodies; use in diagnostic kits for determining presence, onset, or decrease in Leptospiral infection |
| 04/20/2006 | WO2005059108A3 Gene expression profiles and methods of use |
| 04/20/2006 | WO2005052125A3 24p3 receptors and uses thereof |
| 04/20/2006 | WO2005019423A3 Methods and compositions comprising fatp5 for use in the diagnosis and treatment of metabolic disorders |
| 04/20/2006 | WO2005001047A8 N-carbobenzyloxy (n-cbz)-deprotecting enzyme and uses therefor |
| 04/20/2006 | WO2004078935A3 Removal of plastid sequences by transiently expressed site-specific recombinases |
| 04/20/2006 | WO2004044164A3 Method for identifying risk of melanoma and treatments thereof |
| 04/20/2006 | US20060084064 Endocan compositions and methods for the treatment of neoplasms |
| 04/20/2006 | US20060083716 Composition for delivering an agent to a target cell and uses thereof |
| 04/19/2006 | EP1646717A2 Subgroup b adenoviral vectors for treating disease |
| 04/19/2006 | EP1646713A2 Genes encoding carotenoid compounds |
| 04/19/2006 | EP1646712A2 A method for preparing para-hydroxystyrene by biocatalytic decarboxylation of para-hydroxycinnamic acid in a biphasic reaction medium |
| 04/19/2006 | EP1646711A2 Oligodendrocyte precursor cells and methods of obtaining and culturing the same |
| 04/19/2006 | EP1646392A2 7 and 8 membered heterocyclic cyclopentyl benzylamide modulators of chemokine receptor activity |
| 04/19/2006 | CN1761749A Marker for detecting mesenchymal stem cell and method of distinguishing mesenchymal stem cell using the marker |
| 04/19/2006 | CN1761744A Cultured CD14+ antigen presenting cells |
| 04/19/2006 | CN1761482A Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods |
| 04/18/2006 | US7029887 Methods related to Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins |
| 04/13/2006 | WO2006038869A1 Probiotic lactobacillus strains for improved vaginal health |
| 04/13/2006 | WO2006005802A8 Method for stimulating mammalian cells and mammalian cell |
| 04/13/2006 | WO2005051319A3 Plks as modifiers of the beta catenin pathway and methods of use |
| 04/13/2006 | WO2005047487A3 Motoneuronotrophic factor gene sequences |
| 04/13/2006 | WO2004104169A3 Identification and use of genes encoding holins and holin-like proteins in plants for the control of microbes and pests |
| 04/13/2006 | WO2004101757A3 Production of polyunsaturated fatty acids in oleaginous yeasts |
| 04/12/2006 | EP1644734A2 Method for assaying protein-protein interaction |
| 04/12/2006 | EP1644538A2 Methods and compositions for detecting promoter activity and expressing fusion proteins |
| 04/12/2006 | EP1644534A2 Genome mapping of functional dna elements and cellular proteins |
| 04/12/2006 | EP1644533A2 Assay and process for labeling and detection of micro rna and small interfering rna sequences |
| 04/12/2006 | EP1644531A2 Polynucleotides capable of target-dependent circularization and topological linkage |
| 04/12/2006 | EP1644510A2 Plant centromere compositions |
| 04/12/2006 | EP1644502A2 Materials and methods for the modulation of cyclin-dependent kinase inhibitor-like polypeptides in maize |
| 04/12/2006 | EP1644496A2 Modified vectors for organelle transfection |
| 04/12/2006 | EP1644483A2 Use of pleiotrophin in the diagnosis, treatment and prevention of disease |
| 04/12/2006 | EP1644480A2 Insecticidal proteins secreted from bacillus thuringiensis and uses therefor |
| 04/12/2006 | EP1644479A2 Functional synthetic molecules and macromolecules for gene delivery |
| 04/12/2006 | EP1644478A2 Multi-staged absorbable nonwoven structures for culturing pancreatic cells |
| 04/12/2006 | EP1644477A2 Polynucleotides encoding novel adiponectin receptor variants |
| 04/12/2006 | EP1644475A2 DOUBLE STRANDED COMPOSITIONS COMPRISING A 3’-ENDO MODIFIED STRAND FOR USE IN GENE MODULATION |
| 04/12/2006 | EP1644416A2 Engineered anti-target immunoglobulin derived proteins, compositions, methods and uses |
| 04/12/2006 | CN1759184A Expression vectors comprising the MCMV IE2 promoter |
| 04/12/2006 | CN1759178A Variants of enzymes of the alpha-amylase family |
| 04/11/2006 | US7026524 Human coagulation factor VII variants |
| 04/06/2006 | WO2006035104A1 A reactor and method for solid state fermentation |
| 04/06/2006 | WO2005059103A3 Corn plant mon88017 and compositions and methods for detection thereof |
| 04/06/2006 | WO2005017106A3 Libraries of optimized cytochrome p450 enzymes and the optimized p450 enzymes |
| 04/06/2006 | WO2005007798A3 Hydroxypropyl methacrylamide polymers and copolymers comprising reactive thiazoline-2-thione |
| 04/06/2006 | WO2005003321A3 Methods of producing differentiated hematopoietic cells for treatment of cytopenia |
| 04/06/2006 | WO2004094610A3 Wnt as a factor for cardiac myogenesis |
| 04/06/2006 | WO2004085617A3 Timp3 as vegf inhibitor |
| 04/06/2006 | WO2004081191A3 Molecular haplotyping of genomic dna |
| 04/06/2006 | WO2004076621A3 Compositions of nucleic acids for treating and detecting influenza virus |
| 04/06/2006 | WO2004053105A3 Direct SNP detection with unamplified DNA |
| 04/06/2006 | US20060073484 Methods and apparatus for pathogen detection and analysis |
| 04/06/2006 | US20060073137 Humanised antibodies |
| 04/06/2006 | US20060073136 Humanised antibodies |
| 04/06/2006 | CA2581363A1 A reactor and method for solid state fermentation |
| 04/05/2006 | EP1642979A1 Fucosyltransferase gene |
| 04/05/2006 | EP1641930A2 Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with increased tolerance to environmental stress |
| 04/05/2006 | EP1641923A2 Nadks as modifiers of branching morphogenesis and methods of use |
| 04/05/2006 | EP1641910A2 Glucanases, nucleic acids encoding them and methods for making and using them |
| 04/05/2006 | EP1641809A2 Method and compositions for detection and enumeration of genetic variations |
| 04/05/2006 | EP1596667A4 Process for concentration of macromolecules |
| 04/05/2006 | CN1756846A Animal model for the fast identification of pharmaceutical active compounds in vivo |
| 04/05/2006 | CN1249229C Soluble T cell receptor |
| 04/04/2006 | CA2400158C Method of making embryoid bodies from primate embryonic stem cells |
| 03/30/2006 | WO2005040335A3 A novel mutated nerve growth factor beta gene, proteins encoded thereby, and products and methods related thereto |
| 03/30/2006 | WO2005035717A3 Process for the synchronization of ovulation for timed breeding without heat detection |
| 03/30/2006 | WO2005023983A3 Genes having lineage specific variations in copy number and methods of identifying same |
| 03/30/2006 | WO2005003309A3 Pseudopterosin production |
| 03/30/2006 | WO2005001046A3 Methods for predicting the course of a malignant disease |
| 03/30/2006 | WO2004096978A3 Production of high mannose proteins in plant culture |
| 03/30/2006 | WO2004092346A3 Small molecule inhibition of a pdz-domain interaction |
| 03/30/2006 | WO2004090114A3 Compositions and methods of using a synthetic dnase i |
| 03/30/2006 | WO2004076624A3 Compositions and methods for neural cell production and stabilization |
| 03/30/2006 | WO2004070012A3 Cell-killing molecules and methods of use thereof |
| 03/30/2006 | WO2004065568A3 Rapid growing microorganisms for biotechnology applications |
| 03/30/2006 | WO2003062369A3 Expansion of renewable stem cell populations |
| 03/30/2006 | WO2003014294A3 Tacis and br3 polypeptides and uses thereof |
| 03/30/2006 | US20060069064 Methods for facilitating recovery of functions of endogenous or implanted or transplanted stem cells using hyaluronic acid |
| 03/30/2006 | US20060068482 cleaves myeloid/lymphoid or mixed-lineage leukemia protein, which is required for proper HOX gene regulation; Taspase1 inhibitors; leukemia |
| 03/30/2006 | US20060068438 Identification of gene expression alterations underlying the aging process in mammals |
| 03/30/2006 | US20060068405 Methods and systems for annotating biomolecular sequences |
| 03/30/2006 | US20060067924 Probiotic bacteria and methods |
| 03/29/2006 | EP1639137A2 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |